From September 26 to 28, the 8th International Conference on Childhood, Adolescent, and Young Adult Non-Hodgkin Lymphoma (CAYA-NHL) was grandly held in New York, USA, gathering more than 300 top pediatric lymphoma experts and scholars from 25 countries around the world. The expert team from Beijing GoBroad Boren Hospital delivered an outstanding performance at this prestigious international academic forum.

Professor Yonghong Zhang, Medical Director of Beijing GoBroad Boren Hospital and Head of Pediatric Hematology/Oncology, was invited as the only expert from China to join the conference presidium and serve as a session chair, a remarkable honor that reflects the global academic community's recognition of her professional authority.

In addition, Professor Qinlong Zheng from GoBroad Diagnostic Center and the Molecular Diagnostics Laboratory of Beijing GoBroad Boren Hospital delivered an excellent plenary presentation. His research on “Molecular profiling and its prognostic impact of Chinese pediatric patients with T-cell Lymphoblastic Lymphoma” was recognized as internationally leading. The study received high praise from attending experts and was cited multiple times in other conference lectures. Two additional studies from Boren Hospital were selected for poster presentation, further demonstrating the hospital's robust research capabilities and growing international influence in the field of hematologic oncology.

An International Leader in Pediatric Oncology

Professor Yonghong Zhang, Medical Director and Head of Pediatric Hematology/Oncology at Beijing GoBroad Boren Hospital, has devoted more than 40 years to the field of pediatric hematologic malignancies, building extensive clinical experience and profound academic expertise. She was among the first in China to implement internationally aligned precision-stratified chemotherapy protocols, which have increased the cure rate of pediatric lymphoma to 80–90%, reaching advanced international standards.

As a highly productive scholar, Professor Zhang has published over 140 papers as first or corresponding author in top journals such as Blood and Blood Advances, and has served as chief editor of 10 professional monographs, underscoring her remarkable academic achievements. She has also conducted fellowships and academic exchanges at world-renowned institutions, including St. Jude Children's Research Hospital, the Prince of Wales Hospital (Hong Kong), and the MD Anderson Cancer Center (USA), broadening her international perspective.

Her appointment as the only Chinese member of the CAYA-NHL presidium is not only a recognition of her individual excellence, but also a testament to the overall progress of China's pediatric lymphoma field on the global stage.

Scientific Excellence Showcased on the International Stage

At the conference, Professor Qinlong Zheng of the GoBroad Diagnostic Center and Beijing GoBroad Boren Hospital's Molecular Diagnostics Laboratory delivered a plenary talk titled:“Molecular profiling and its prognostic impact of Chinese pediatric patients with T-cell Lymphoblastic Lymphoma.”

The study focused on the correlation between fusion/mutated genes and clinical prognosis in pediatric T-cell lymphoblastic lymphoma (T-LBL), identifying several gene fusions reported globally for the first time.

Following the presentation, experts engaged in in-depth discussion and highly commended the study's innovation and forward-looking value. Notably, the earlier phase of this research on NOTCH fusion genes in T-LBL has already been published, and several international experts cited it during their lectures at the meeting—further affirming its frontline position and academic influence worldwide.

This research offers new hope for improving prognosis and treatment outcomes for pediatric lymphoma patients globally, showcasing the emergence and leadership of Chinese medical research on the world stage and advancing international collaboration in healthcare innovation.

Poster Highlights: Frontier Studies Gain Wide Attention

In addition to the oral presentation, two research projects from Beijing Boren Hospital were featured as posters:

 Continuing to Drive Innovation and Global Collaboration

The brilliant performance of Boren Hospital expert team at this conference not only highlights the hospital's scientific strength and international influence in pediatric hematologic oncology but also provides new insights and treatment strategies for children with lymphoma worldwide.

Looking ahead, Beijing GoBroad Boren Hospital will continue to uphold the philosophy of “dual-driven development in clinical practice and scientific research,” fostering continuous exploration and innovation, and contributing greater wisdom and strength to the global fight against pediatric hematologic malignancies.